media – Page 575 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Contraceptive app hit with complaints after being blamed for 37 unwanted pregnancies

Natural Cycles, a contraceptive app that became certified in the EU as a form of birth control, has been hit with a complaint after being blamed for causing 37 unwanted pregnancies
- Source: The Verge
- 623
- January 17, 2018
Company Insight mHealth pregnancy
NHS Adopts Early Warning Sepsis System

NHS officials have surmised that a system that identifies seriously ill patients would save approximately 2,000 lives a year. They have also estimated that 627,000 ‘bed days’ could be saved as a result.
- Source: Celebrity Angels
- 557
- January 17, 2018
New Approvals NHS sepsis
Three ways you can act to reduce the risk

If 2017 was about ransomware attacks, 2018 will be about cyber attacks on the Internet of Things (aka medical devices).
- Source: Xceptional
- 770
- January 17, 2018
health IT medical device Researches
Immune Cells Play Key Role in Early Breast Cancer Metastasis Even Before a Tumor Develops

Mount Sinai researchers have discovered that normal immune cells called macrophages, which reside in healthy breast tissue surrounding milk ducts, play a major role in helping early breast cancer cells leave the breast for other parts of the body, potentially creating metastasis before a tumor has even developed, according to a study published in Nature Communications.
- Source: mountsinai.org
- 545
- January 16, 2018
breast cancer macrophages Researches
GBT Receives FDA Breakthrough Therapy Designation for Voxelotor for Treatment of Sickle Cell Disease (SCD)

Global Blood Therapeutics, Inc. (GBT) (GBT) announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to voxelotor (previously called GBT440) for the treatment of sickle cell disease (SCD). Voxelotor is being developed as a disease-modifying therapy for SCD and previously received European Medicines Agency (EMA) Priority Medicines (PRIME) designation for the treatment of SCD.
- Source: finance.yahoo
- 540
- January 16, 2018
FDA New Approvals SCD Voxelotor
Teva Announces U.S. FDA Approval of TRISENOX (arsenic trioxide) Injection for First Line Treatment of Acute Promyelocytic Leukemia

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced that the U.S. Food and Drug Administration (FDA) has approved the use of TRISENOX® (arsenic trioxide) injection in combination with tretinoin for the treatment of adults with newly-diagnosed low-risk acute promyelocytic leukemia (APL) whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression. The approval was based on a Priority Review by the FDA on data from published scientific literature and a review of Teva’s global safety database for arsenic trioxide
- Source: finance.yahoo
- 552
- January 16, 2018
APL arsenic trioxide FDA New Approvals Teva TRISENOX
Iodine deficiency may lead to pregnancy delays

Women attempting pregnancy may experience difficulty or delays in conceiving when they have moderate or severe iodine deficiency, according to findings published in Human Reproduction.
- Source: healio
- 488
- January 16, 2018
iodine deficiency pregnancy Researches
Adoption of cloud-based imaging informatics tools set to accelerate

According to the Frost & Sullivan study, the total revenue of the global cloud-based medical imaging informatics market is expected to remain on a very strong growth trajectory over the next few years, growing from $285.4 million in 2016 to $830.5 million in 2021. That's a significant compound annual growth rate of 23.8 percent.
- Source: Healthcare IT news
- 453
- January 16, 2018
health IT imaging Market Views
Newly FDA-Approved Platform Will Rapidly “Manufacture” Stem Cells to Repair Our Bodies

Stem cells have the unique capability to transform into any sort of specialized cell needed in the body, making them especially promising for medicine that replaces nonfunctional or dead cells.
- Source: Futurism
- 490
- January 16, 2018
FDA New Approvals stem cells
FDA approves algorithm that predicts sudden patient deaths to help prevent them

Wave Clinical Platform is the work of ExcelMedical and is a system that monitors patients' vital signs, sending alerts that warn of potentially fatal heart attacks or respiratory failure up to six hours before a patient suffers such an event.
- Source: Digital Trends
- 509
- January 16, 2018
FDA healthcare technology New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.